Baylor College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).
Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.
Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.
Top-decile sponsor footprint
Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
616 total, page 10 of 13
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
NCT00709033
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
NCT00950677
Rivastigmine as a Treatment for Methamphetamine Dependence
NCT01073319
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
NCT00799435
Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children
NCT00901316
Investigation of Cycloserine as a Smoking Cessation Treatment
NCT01062932
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
NCT01062451
Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy
NCT00889954
Prostate Cancer Symptom Management for Low Literacy Men
NCT00983710
Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus
NCT00880789
Calmer Life: A Worry Reduction Program for Older Adults
NCT00932178
Study of the Safety and Efficacy of Botox in Bruxism
NCT00908050
Evaluation of Calcium, Vitamin D, Magnesium, and Zinc Absorption in Children
NCT00868738
Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair
NCT01053637
Amitiza in Constipation Associated With PD (Parkinson's Disease)
NCT00908076
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
NCT01030692
Recurrent Abdominal Pain in Children
NCT00526903
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
NCT00711035
Optimization of IV Ketamine for Treatment Resistant Depression
NCT00768430
Impact of an Online Behavioral Weight Loss Program
NCT01492413
Zinc and Copper Absorption in Neonates With Bilious Losses
NCT00738283
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
NCT00738101
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
NCT00828633
Expressive Writing for Co-Occurring Depression and Alcohol Misuse
NCT00818636
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
NCT00717483
Impact of Vitamin D Status on Bones in Breastfed Infants
NCT00697294
Genetic Susceptibility to Kidney Cancer
NCT00854022
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
NCT00704379
Pilot RCT of an Obesity Intervention for Primary Care Pediatrics: Helping HAND
NCT01195012
Disaster Preparedness Among Families Caring for Children With Diabetes
NCT00781313
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells
NCT00703222
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
NCT00665769
Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care
NCT00765219
Postoperative Effects of Intranasal Fentanyl, IV and IM Morphine in Children Undergoing Myringotomy
NCT01244126
Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer
NCT00769431
Propofol in Obese Children
NCT01242241
Effect of Vitamin C on Iron Absorption
NCT00570895
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
NCT00596284
Perceived Lactose Intolerance
NCT01331265
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
NCT00691600
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
NCT00578461
T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
NCT00578539
Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders
NCT00579137
Understanding Sleep Problems in Children With Autism Spectrum Disorder
NCT00691080
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
NCT00516087
Conjoint Analysis of Treatment Preferences for Osteoarthritis
NCT01003925
Bladder Cancer Patient-Reported Outcomes
NCT01090388
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting
NCT00717613
Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)
NCT00711087
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
NCT01432405
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 173 |
| Phase 2 | 59 |
| Phase 3 | 13 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the Baylor College of Medicine pipeline
93 recruiting of 616 indexed (15% open); 376 completed (61%).
Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor College of Medicine: open-pipeline peers nationwide
Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 616 trials (± recruiting share)
- University of Southern California · 617 trials · 16% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Stanford University · 15% recruiting · 1,744 trials
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- 59th Medical Wing · 15% recruiting · 20 trials
Related
What to do with this Baylor College of Medicine page
616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.
- 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.